
|Articles|November 13, 2014
New Drug Targets May Lead to Effective Ebola Treatments
Advertisement
There are no approved treatments or preventives against Ebola virus disease, but investigators have now designed peptides that mimic the virus' N-trimer, a highly conserved region of a protein that's used to gain entry inside cells.
The team showed that the peptides can be used as targets to help researchers develop drugs that might block Ebola virus from entering into cells.
"In contrast to the most promising current approaches for Ebola treatment or prevention, which are species-specific, our 'universal' target will enable the selection of broad-spectrum inhibitors that should block all known--and likely future--Ebola strains," says Dr. Michael Kay, senior author of the Protein Science study.
Source: Wiley
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Infection Control Today
1
Cyclospora First Deaths: Expert Explains Why Cases Are So Difficult to Trace and What Infection Preventionists Should Know
2
New US Ebola Travel Restrictions: What Infection Preventionists Need to Know About the 21-Day Return Policy
3
How Claryx Uses Genomics to Help Infection Prevention Teams Find Outbreaks Faster
4
Roche Expands Cyclospora PCR Testing Portfolio to Support Ongoing US Outbreak Response
5






